Jacques Bradwejn

7.2k total citations
144 papers, 5.4k citations indexed

About

Jacques Bradwejn is a scholar working on Cellular and Molecular Neuroscience, Experimental and Cognitive Psychology and Molecular Biology. According to data from OpenAlex, Jacques Bradwejn has authored 144 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 75 papers in Cellular and Molecular Neuroscience, 39 papers in Experimental and Cognitive Psychology and 36 papers in Molecular Biology. Recurrent topics in Jacques Bradwejn's work include Neuropeptides and Animal Physiology (66 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (37 papers) and Receptor Mechanisms and Signaling (28 papers). Jacques Bradwejn is often cited by papers focused on Neuropeptides and Animal Physiology (66 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (37 papers) and Receptor Mechanisms and Signaling (28 papers). Jacques Bradwejn collaborates with scholars based in Canada, Estonia and France. Jacques Bradwejn's co-authors include Diana Koszycki, Eero Vasar, Michel Bourin, Jakov Shlik, Greg B. Meterissian, Claude de Montigny, Jaanus Harro, Franco J. Vaccarino, L Annable and Bernárd P. Roques and has published in prestigious journals such as Nature, Journal of Neuroscience and SHILAP Revista de lepidopterología.

In The Last Decade

Jacques Bradwejn

143 papers receiving 5.2k citations

Peers

Countries citing papers authored by Jacques Bradwejn

Since Specialization

Citations

This map shows the geographic impact of Jacques Bradwejn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacques Bradwejn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacques Bradwejn more than expected).

Fields of papers citing papers by Jacques Bradwejn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacques Bradwejn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacques Bradwejn. The network helps show where Jacques Bradwejn may publish in the future.

Co-authorship network of co-authors of Jacques Bradwejn

This figure shows the co-authorship network connecting the top 25 collaborators of Jacques Bradwejn. A scholar is included among the top collaborators of Jacques Bradwejn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacques Bradwejn. Jacques Bradwejn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Interpersonal Psychotherapy for the Treatment of Depression in Parkinson's Disease: Results of a Randomized Controlled Trial 2024 ·Movement Disorders ·Diana Koszycki, Monica Taljaard, Jacques Bradwejn, Caroline Lee, Giorgio A. Tasca, David A. Grimes	2
2	Interpersonal Psychotherapy for Depression in Parkinson’s Disease: A Feasibility Study 2022 ·Journal of Geriatric Psychiatry and Neurology ·Diana Koszycki, Monica Taljaard, Cary S. Kogan, Jacques Bradwejn, David A. Grimes	4
3	Does treatment preference affect outcome in a randomized trial of a mindfulness intervention versus cognitive behaviour therapy for social anxiety disorder? 2021 ·Clinical Psychology & Psychotherapy ·Diana Koszycki, (unknown), (unknown), Jacques Bradwejn	4
4	Randomized trial of cognitive behaviour group therapy and a mindfulness‐based intervention for social anxiety disorder: Preliminary findings 2020 ·Clinical Psychology & Psychotherapy ·Diana Koszycki, Eva Guérin, (unknown), Jacques Bradwejn	19
5	Predictors of etiological beliefs about panic disorder and impact of beliefs on treatment outcomes 2018 ·Psychiatry Research ·(unknown), Diana Koszycki, Monica Taljaard, Zindel V. Segal, Jacques Bradwejn	6
6	Preliminary Investigation of a Mindfulness-Based Intervention for Social Anxiety Disorder That Integrates Compassion Meditation and Mindful Exposure 2016 ·The Journal of Alternative and Complementary Medicine ·Diana Koszycki, Jennifer Thake, (unknown), (unknown), Monica Taljaard, Jacques Bradwejn	42
7	A New Leadership Curriculum 2014 ·Academic Medicine ·(unknown), Jacques Bradwejn, Erick M. Westbroek	13
8	Impaired Facial Affect Perception in Unaffected Children at Familial Risk for Panic Disorder 2014 ·Child Psychiatry & Human Development ·(unknown), Jacques Bradwejn, Diana Koszycki	3
9	Interpersonal psychotherapy versus brief supportive therapy for depressed infertile women: first pilot randomized controlled trial 2012 ·Archives of Women s Mental Health ·Diana Koszycki, J.C. Bisserbe, Pierre Blier, Jacques Bradwejn, John C. Markowitz	37
10	A Randomized Controlled Trial of Venlafaxine Extended Release in Generalized Social Anxiety Disorder 2005 ·The Journal of Clinical Psychiatry ·Michael R. Liebowitz, Richard M. Mangano, Jacques Bradwejn, Gregory M. Asnis	78
11	Assessing patient beliefs in a clinical trial ofHypericum perforatum in major depression 2004 ·Depression and Anxiety ·Carla Bann, Corette B. Parker, Jacques Bradwejn, Jonathan Davidson, Benedetto Vitiello, Kishore M. Gadde	29
12	Effect of Aging on Cholecystokinin-Induced Panic 1998 ·American Journal of Psychiatry ·Alastair J. Flint, Diana Koszycki, Franco J. Vaccarino, Alain Cadieux, Jean‐Philippe Boulenger, Jacques Bradwejn	40
13	The role of the β-noradrenergic system in cholecystokinin-tetrapeptide-induced panic symptoms 1998 ·Biological Psychiatry ·Jean‐Michel Le Mellédo, Jacques Bradwejn, Diana Koszycki, Daniel G. Bichet, François Bellavance	22
14	Inhibition of nitric oxide synthase causes anxiolytic-like behaviour in an elevated plus-maze 1995 ·Neuroreport ·Vallo Volke, Sulev Kõks, Eero Vasar, Michel Bourin, Jacques Bradwejn, Pekka T. Männistö	77
15	The Cholecystokinin Hypothesis of Anxiety and Panic Disordera 1994 ·Annals of the New York Academy of Sciences ·Jacques Bradwejn, Diana Koszycki	83
16	The Panicogenic Effects of Cholecystokinin-Tetrapeptide Are Antagonized by L-365,260, a Central Cholecystokinin Receptor Antagonist, in Patients With Panic Disorder 1994 ·Archives of General Psychiatry ·Jacques Bradwejn	141
17	Subdiaphragmatic vagotomy does not prevent the anti-exploratory effect of caerulein in the elevated plus-maze 1994 ·Neuropeptides ·Eero Vasar, A. Lang, Jaanus Harro, Sulev Kõks, Vallo Volke, (unknown), Michel Bourin, Jacques Bradwejn, Pekka T. Männistö	8
18	Benzodiazepines for the treatment of panic disorder and generalized anxiety disorder: clinical issues and future directions. 1993 ·PubMed ·Jacques Bradwejn	14
19	L-365,260, A CCKB ANTAGONIST, BLOCKS CCK-4-PANIC IN PANIC DISORDER 1992 ·Clinical Neuropharmacology ·Jacques Bradwejn, Diana Koszycki, (unknown), Harold J.G.M. van Megen, (unknown), H.G.M. Westenberg, (unknown), Jody J. Haigh	7
20	Enhanced Sensitivity to Cholecystokinin Tetrapeptide in Panic Disorder 1991 ·Archives of General Psychiatry ·Jacques Bradwejn	287

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact